Eversana Acquires Cornerstone Research Group to Enhance Global HEOR Capabilities

On November 1, 2019, VCBeat (WeChat ID: vcbeat) learned via Business Wire that private equity firm Eversana had announced the acquisition of Cornerstone Research Group, a Canadian health economics and market access research company. No financial terms of the acquisition were disclosed.

Cornerstone Research Group will transition to Eversana in the next quarter, with its partners Chris Cameron, Daniel Grima, and Melissa Thompson assuming leadership roles at Eversana.

Eversana provides a fully integrated and independent commercial services platform designed to address global pricing, market access, reimbursement, compliance, and product delivery challenges in the life sciences sector.

By acquiring Cornerstone Research Group, EVERSANA has enhanced its global integrated HEOR capabilities, including economic modeling, evidence synthesis, value communication, and reimbursement strategies across all stages of the product lifecycle.

Eversana is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions, rooted in patient experience, span all stages of the product lifecycle, delivering long-term, sustainable value to patients, healthcare providers, channel partners, and payers. To date, Eversana has served more than 500 organizations, ranging from innovative startups to established pharmaceutical companies, advancing life sciences solutions toward better health outcomes.

Jim Lang, CEO of EVERSANA, stated, “Pharmaceutical companies are under significant pressure to rapidly assess and quantify the direct and indirect value of their marketed products and development pipelines. By integrating robust health economics and outcomes research (HEOR) capabilities into our integrated commercial platform, we can now conceptualize, deliver, and measure value across all stages of the product lifecycle—from clinical trials to long-term patient adherence. The Cornerstone Research Group team brings extensive expertise and experience that will deliver substantial value to our global clients, and we are thrilled to welcome them aboard.”

Melissa Thompson, a partner at Cornerstone Research Group, stated, “We are delighted to join the Eversana family. In today’s pharmaceutical industry, the demand for evidence-based research has never been stronger. Eversana’s integrated platform enables our existing clients to immediately access expanded services and solutions, and we also see significant opportunities to provide HEOR services to current Eversana clients. Furthermore, Eversana represents a perfect cultural fit for our employees, offering a bright future for all.”

Cornerstone Research Group is a global health economics and market access research firm. Established in 2005, the company is headquartered in Burlington, Ontario, with an additional office in Sydney, Nova Scotia, providing support to pharmaceutical and medical device companies. Initially, Cornerstone Research Group focused on building partners’ expertise in health economics research, primarily concentrating on global cost-effectiveness models and reimbursement submissions in Canada. Subsequently, the company has strategically expanded by adding world-class teams for evidence synthesis and data analysis, enhancing its outstanding payer communication capabilities, and supporting global projects through submission strategies in key markets.

(Compiled by Wang Fang)